{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:52:16Z","timestamp":1790117536078,"version":"4.0.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["K23NS118048"],"award-info":[{"award-number":["K23NS118048"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.cell.2026.06.011","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T16:55:06Z","timestamp":1783616106000},"page":"4188-4189","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Rewriting Duchenne muscular dystrophy therapy"],"prefix":"10.1016","volume":"189","author":[{"given":"Paloma","family":"Gonzalez-Perez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Blackstone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cell.2026.06.011_bib1","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3390\/muscles5010021","article-title":"Duchenne muscular dystrophy: contemporary therapeutic options and real-world challenges in treatment selection","volume":"5","author":"Pesco","year":"2026","journal-title":"Muscles"},{"key":"10.1016\/j.cell.2026.06.011_bib2","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1016\/j.ymthe.2025.04.038","article-title":"Clinical applications of exon-skipping antisense oligonucleotides in neuromuscular diseases","volume":"33","author":"Torres-Masjoan","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.cell.2026.06.011_bib3","doi-asserted-by":"crossref","first-page":"4377","DOI":"10.1016\/j.cell.2026.05.030","article-title":"Long-term reversal of Duchenne muscular dystrophy via circular arRNA-guided exon skipping in monkeys and humans","volume":"189","author":"Guo","year":"2026","journal-title":"Cell"},{"key":"10.1016\/j.cell.2026.06.011_bib4","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/s41587-019-0178-z","article-title":"Programmable RNA editing by recruiting endogenous ADAR using engineered RNAs","volume":"37","author":"Qu","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.cell.2026.06.011_bib5","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/s41587-021-01180-3","article-title":"Engineered circular ADAR-recruiting RNAs increase the efficiency and fidelity of RNA editing in vitro and in vivo","volume":"40","author":"Yi","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.cell.2026.06.011_bib6","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s13059-023-03086-6","article-title":"Utilizing AAV-mediated LEAPER 2.0 for programmable RNA editing in non-human primates and nonsense mutation correction in humanized Hurler syndrome mice","volume":"24","author":"Yi","year":"2023","journal-title":"Genome Biol."},{"key":"10.1016\/j.cell.2026.06.011_bib7","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1056\/NEJMc2212912","article-title":"Dystrophin immunity after gene therapy for Duchenne\u2019s muscular dystrophy","volume":"388","author":"B\u00f6nnemann","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cell.2026.06.011_bib8","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000213604","article-title":"Delandistrogene moxeparvovec gene therapy in individuals with Duchenne muscular dystrophy: evidence in focus: report of the AAN Guidelines Subcommittee","volume":"104","author":"Oskoui","year":"2025","journal-title":"Neurology"},{"key":"10.1016\/j.cell.2026.06.011_bib9","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00176-2023","article-title":"Cardiomyopathy as cause of death in Duchenne muscular dystrophy: a longitudinal observational study","volume":"9","author":"Lechner","year":"2023","journal-title":"ERJ Open Res."},{"key":"10.1016\/j.cell.2026.06.011_bib10","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/s41467-025-56644-w","article-title":"Duchenne muscular dystrophy: recent insights in brain related comorbidities","volume":"16","author":"Vaillend","year":"2025","journal-title":"Nat. Commun."}],"container-title":["Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867426006987?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867426006987?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T21:54:51Z","timestamp":1785880491000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0092867426006987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":10,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0092867426006987"],"URL":"https:\/\/doi.org\/10.1016\/j.cell.2026.06.011","relation":{},"ISSN":["0092-8674"],"issn-type":[{"value":"0092-8674","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rewriting Duchenne muscular dystrophy therapy","name":"articletitle","label":"Article Title"},{"value":"Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cell.2026.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.cell.2026.05.030","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}